相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management
Lei Peng et al.
STEM CELL RESEARCH & THERAPY (2022)
Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus
Tsung-Hui Wu et al.
PLOS ONE (2022)
Circulating beta 2 and alpha 1 microglobulins predict progression of nephropathy in diabetic patients: a meta-analysis of prospective cohort studies
Alieh Gholaminejad et al.
ACTA DIABETOLOGICA (2022)
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Amanda H. Anderson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
The Treatment Effectiveness Evaluation for Slowing the Progression of Diabetic Nephropathy During Stage 4 Chronic Kidney Disease
Tianyu Yu et al.
DIABETES THERAPY (2021)
Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm
Alieh Gholaminejad et al.
BMC NEPHROLOGY (2021)
Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Meta-Analysis of 20 Cohorts
Wenhui Jiang et al.
DIABETES CARE (2020)
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
Nicholas M. Selby et al.
DIABETES OBESITY & METABOLISM (2020)
Biological variation of cardiac troponins in chronic kidney disease
R. A. Jones et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2020)
Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
Lijun Zhao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Diabetic Kidney Disease: Challenges, Advances, and Opportunities
Ya Chen et al.
KIDNEY DISEASES (2020)
Circulating TNF receptors 1 and 2 predict progression of diabetic kidney disease: A meta-analysis
Xiaoqi Ye et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis
Kwok Leung Ong et al.
ATHEROSCLEROSIS (2019)
Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes
Michael Kammer et al.
KIDNEY INTERNATIONAL (2019)
Serum kidney injury molecule 1 and 2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes
Marco Colombo et al.
DIABETOLOGIA (2019)
Diagnostic Accuracy of Neutrophil Gelatinase-Associated Lipocalin for Predicting Early Diabetic Nephropathy in Patients with Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Georgia Kapoula et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2019)
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
Andreas Heinzel et al.
DIABETES CARE (2018)
Clinical predictive biomarkers for normoalbuminuric diabetic kidney disease
Tomohito Gohda et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies
Alieh Gholaminejad et al.
JOURNAL OF NEPHROLOGY (2018)
Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes
Ryo Sawada et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2018)
Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease
Steven G. Coca et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy
Julie Galsgaard et al.
KIDNEY INTERNATIONAL (2017)
The Association between Biomarker Profiles, Etiology of Chronic Kidney Disease, and Mortality
David Langsford et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes
Sara J. Jenks et al.
DIABETOLOGIA (2017)
Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy
Arash Bidadkosh et al.
DIABETES CARE (2017)
Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
Xin Mou et al.
PLOS ONE (2016)
Urinary Markers of Tubular Injury in Early Diabetic Nephropathy
Temesgen Fiseha et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2016)
Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
Helen C. Looker et al.
KIDNEY INTERNATIONAL (2015)
Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis
Mehdi Javanbakht et al.
PLOS ONE (2015)
Kidney injury molecule-1 as a predicting factor for inflamed kidney, diabetic and diabetic nephropathy Egyptian patients
Samia A. Ahmed et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2015)
Cardiovascular Complications of Diabetic Kidney Disease
Ragnar Palsson et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial
Paul Welsh et al.
DIABETES CARE (2014)
Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes
Venkata. S. Sabbisetti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The Impacts of Albuminuria and Low eGFR on the Risk of Cardiovascular Death, All-Cause Mortality, and Renal Events in Diabetic Patients: Meta-Analysis
Tadashi Toyama et al.
PLOS ONE (2013)
NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study
Gabriella Gruden et al.
DIABETES CARE (2012)
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
Bakhtawar K. Mahmoodi et al.
LANCET (2012)
Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
Akshay S. Desai et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes
Jakob Grauslund et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy
Frederick W. K. Tam et al.
CYTOKINE (2009)
Screening for CKD with eGFR: Doubts and dangers
Richard J. Glassock et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Cardiac troponins
Scott M. Wells et al.
JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE (2008)
Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes
L. Tarnow et al.
DIABETOLOGIA (2006)
NT-ProBNP: The mechanism behind the marker
C Hall
JOURNAL OF CARDIAC FAILURE (2005)
Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy
L Tarnow et al.
DIABETOLOGIA (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
分享论文
